A Mason
Topical treatments for chronic plaque psoriasis: an abridged Cochrane Systematic Review
Mason, A; Mason, JM; Cork, M; Hancock, H; Dooley, G
Authors
JM Mason
M Cork
H Hancock
G Dooley
Abstract
Background: Chronic plaque psoriasis is the most common type of psoriasis and is characterized by redness, thickness, and scaling. First-line management is with topical treatments. Objective: We sought to undertake a Cochrane review of topical treatments for chronic plaque psoriasis. Methods: We systematically searched major databases for randomized controlled trials. Trials reported improvement using a range of related measures; standardized, pooled findings were translated onto a 6-point improvement scale. Results: The review included 177 randomized controlled trials with 34,808 participants, including 26 trials of scalp psoriasis and 6 trials of inverse and/or facial psoriasis. Typical trial duration was 3 to 8 weeks. When compared with placebo (emollient base), the average improvement for vitamin-D analogues and potent corticosteroids was approximately 1 point, dithranol 1.2 points, very potent corticosteroids 1.8 points, and combined vitamin-D analogue plus steroid 1.4 points once daily and 2.2 points twice daily. However, these are indicative benefits drawn from heterogeneous trial findings. Corticosteroids were more effective than vitamin D for treating psoriasis of the scalp. For both body and scalp psoriasis, potent corticosteroids were less likely than vitamin D to cause skin irritation. Limitations: Reporting of benefits, adverse effects, and safety assessment methods was often inadequate. In many comparisons, heterogeneity made the size of treatment benefit uncertain. Conclusions: Corticosteroids are as effective as vitamin-D analogues and cause less skin irritation. However, further research is needed to inform long-term maintenance treatment and provide appropriate safety data.
Citation
Mason, A., Mason, J., Cork, M., Hancock, H., & Dooley, G. (2013). Topical treatments for chronic plaque psoriasis: an abridged Cochrane Systematic Review. Journal of The American Academy of Dermatology, 69(5), 799-807. https://doi.org/10.1016/j.jaad.2013.06.027
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 2, 2013 |
Online Publication Date | Oct 11, 2013 |
Publication Date | Oct 11, 2013 |
Deposit Date | Oct 31, 2013 |
Publicly Available Date | Jan 6, 2017 |
Journal | Journal of The American Academy of Dermatology |
Print ISSN | 0190-9622 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 69 |
Issue | 5 |
Pages | 799-807 |
DOI | https://doi.org/10.1016/j.jaad.2013.06.027 |
Public URL | https://durham-repository.worktribe.com/output/1447766 |
Files
Accepted Journal Article
(501 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
© 2013 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search